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Pathogens adapt to the host environment by altering
their patterns of gene expression. Microarray-based
and genetic techniques used to characterize bacte-
rial gene expression during infection are limited in
their ability to comprehensively and simultaneously
monitor genome-wide transcription. We used mas-
sively parallel cDNA sequencing (RNA-seq) tech-
niques to quantitatively catalog the transcriptome of
the cholera pathogen, Vibrio cholerae, derived from
two animal models of infection. Transcripts elevated
in infected rabbits and mice relative to laboratory
media derive from the major known V. cholerae
virulence factors and also from genes and small
RNAsnotpreviously linked to virulence. TheRNA-seq
data was coupled with metabolite analysis of cecal
fluid from infected rabbits to yield insights into the
host environment encountered by the pathogen
and the mechanisms controlling pathogen gene ex-
pression. RNA-seq-based transcriptome analysis of
pathogens during infection produces a robust, sensi-
tive, and accessible data set for evaluation of regula-
tory responses driving pathogenesis.
INTRODUCTION
Cholera is a severe and sometimes lethal diarrheal disease
that has afflicted human populations for centuries and remains
a significant threat to public health in many parts of the world.
In addition to seasonal cholera epidemics on the Indian subcon-
tinent, major cholera epidemics have occurred during the last
two decades in several countries in Africa (World Health Organi-
zation, 2010). The ongoing cholera epidemic in Haiti, which
began in October 2010, has signaled the return of cholera to
the western hemisphere (Chin et al., 2011).
Cholera is caused by Vibrio cholerae. This curved gram-
negative rod has the unusual capacity to survive and multiplyCell Hos(colonize) in the human small intestine, where it produces cholera
toxin (CT). This AB5-type toxin causes marked secretion of
Cl and water from intestinal epithelial cells into the bowel
lumen and is the direct cause of cholera’s hallmark diarrhea
(Sa´nchez and Holmgren, 2008). While many bacterial factors
and processes contribute to V. cholerae’s capacity to colonize
the small intestine (Ritchie and Waldor, 2009), a principal and
essential factor is the type IV pilus TCP (Taylor et al., 1987).
Two transcriptional regulators, ToxR and ToxT, are critical for
coordinated expression of the genes encoding the biosynthesis
of TCP andCT (ctxAB) (Krukonis and DiRita, 2003). Notably, both
CT and TCP are encoded within mobile (or formerly mobile)
genetic elements (Waldor and Mekalanos, 1996; Kovach et al.,
1996).
Animal models have been valuable for exploring V. cholerae
pathogenicity. Ligated rabbit ileal loops were used to demon-
strate that cell-free supernatants from V. cholerae cultures con-
tain an enterotoxic activity (now known to be CT) (De, 1959);
however, this model circumvents the normal route of infection.
Infant mice have been extremely useful for discovering genes
that facilitate or are required for V. cholerae intestinal coloniza-
tion (Ritchie and Waldor, 2009), such as those enabling produc-
tion of TCP (Taylor et al., 1987; Herrington et al., 1988). However,
one drawback of infant mice is that they do not develop overt
diarrhea. In contrast, orogastric infection of cimetidene-treated
infant rabbits with V. cholerae routinely leads to CT- and TCP-
dependent cholera-like illness (Ritchie et al., 2010).
A central aim of studies of microbial pathogenesis is to under-
stand how the host environment alters the global pattern of
pathogen gene expression (Hsiao and Zhu, 2009). Both genetic
and microarray-based high throughput approaches have been
used to identify V. cholerae genes induced during infection (Mer-
rell et al., 2002; Xu et al., 2003; Bina et al., 2003; Larocque et al.,
2005). Genetic screens, which to date have relied on recombi-
nase-based in vivo expression technology (RIVET), have
been limited by bottlenecks in the host and a requirement that
in vivo-induced genes be transcriptionally silent in vitro, which
hampered assessment of whether the TCP biosynthesis genes
are induced in vivo (Lombardoet al., 2007). RIVET-based screens
also do not allow for detection of genes that are transcriptionally
silenced during infection. Fluorescent reporter-based screenst & Microbe 10, 165–174, August 18, 2011 ª2011 Elsevier Inc. 165
Table 1. Summary of Illumina and Helicos RNA-Seq Data
Growth
Condition Sample
Number of
aligned
reads
(millions)
Number of
non-rRNA
reads
(millions)
R-value
(tech reps) (biol reps)
Illumina
LB 1a* 38.8 6.8 >0.99 0.93
1b* 53.5 22.8
2 44.7 16.4
M9 1a# 54.8 18.5 >0.99 0.99
1b# 54.3 19.0
2 47.9 20.0
Rabbit 1 39.6 12.0 N/A 0.84
2 27.8 8.5
Helicos
LB 1 5.2 449.1 N/A 0.99
2 4.0 362.8
Mouse$ 1 4.5 283.7 N/A 0.83
2 1.0 61.2
*,#: Technical replicates.
$: Each mouse sample had more than 100 million reads.
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but have been less useful in identifying in vivo induced genes
(Hsiao and Zhu, 2009). In contrast, microarray-based studies
can detect both increases and decreases in gene expression
during infection; however, microarrays usually do not contain
complete representations of the genome (Merrell et al., 2002;
Xu et al., 2003; Bina et al., 2003; Larocque et al., 2005). For
example, all of the microarrays that have been used to analyze
the V. cholerae transcriptome did not enable detection of non-
coding RNAs. Furthermore, it is often difficult to compare micro-
array results that come from different laboratories as different
approaches have been used to analyze data.
The development of massively parallel cDNA sequencing
(RNA-seq) techniques is enabling deeper and more accurate
assessment of transcriptomes from eukaryotes (Ozsolak and
Milos, 2011) as well as bacteria (van Vliet, 2010; Sorek and
Cossart, 2010). In contrast to hybridization-based methods
such as microarrays, RNA-seq allows for unbiased annotation-
independent detection of transcripts, increased sensitivity, and
higher resolution (Croucher and Thomson, 2010). In bacterial
pathogens, RNA-seq studies have been used to comprehen-
sively map transcription start sites and operon structures (Cho
et al., 2009; Sharma et al., 2010) and discover sRNAs (Sittka
et al., 2008; Liu et al., 2009; Cho et al., 2009; Sharma et al.,
2010; Irnov et al., 2010; Weissenmayer et al., 2011). However,
to date this technology has not been applied to investigation of
the global patterns of pathogen gene expression during infection
of a mammalian host.
Here we used RNA-seq to generate comprehensive transcrip-
tome profiles of V. cholerae during growth in the intestines of
infant rabbits and infant mice as well as in laboratory cultures.
Genes induced in vivo in bothmodel hosts included all the known
V. cholerae virulence factors including genes for CT and TCP
biosynthesis as well as many genes encoding proteins and166 Cell Host & Microbe 10, 165–174, August 18, 2011 ª2011 Elsevismall RNAs not previously linked to infection. Contribution of
the in vivo-induced genes identified in this study to intestinal
colonization was also assessed. Furthermore, comparative anal-
yses of metabolites present in culture supernatants and in cecal
fluid from infected rabbits were used to infer explanations for
some of the observed patterns of V. cholerae gene expression.
Collectively, our findings indicate that RNA-seq is a powerful
tool that can enable monitoring of pathogen gene expression
during infection.
RESULTS AND DISCUSSION
V. cholerae, like other faculative pathogens, modulates its gene
expression upon infection of its mammalian host. To gain under-
standing of V. cholerae’s adaptation to the host environment, we
systematically cataloged the transcriptomes of bacteria grown
in vivo and in vitro, using high-throughput cDNA sequencing
techniques. RNA was derived from organisms either grown in
laboratory medium, isolated directly from the fluid that accumu-
lates in the ceca of orally infected infant rabbits, or contained
within small intestinal homogenates of orally infected infant
mice. Strand-specific Illumina-based RNA-seq (Levin et al.,
2010) was used for characterization of bacteria within cecal fluid,
which reach densities of 5 3 108 V. cholerae cfu/ml. Helicos-
based sequencing, which required less manipulation of the
relatively small amount of bacterial RNA obtained from the infant
mouse intestinal homogenates, was used to assess V. cholerae
transcript abundance in infected mice.
Between 8 and 12 million reads for each rabbit cecal sample
(n = 2) aligned to non-rRNA regions of the V. cholerae genome,
and a similar number of reads were obtained for the in vitro
grown control samples (Table 1). Fewer of the reads derived
frommurine samples (n = 2, 284,000, and 61,000 reads per intes-
tinal sample) aligned to non-rRNA sequences in the V. cholerae
genome, both because of the abundance of host and normal
flora-derived transcripts and because rRNAs were not depleted
prior to sequencing. Nonetheless, the reproducibility (R value) of
the transcriptome data derived from the murine samples was
equal to that obtained from the rabbit cecal fluid isolates (Table
1). Importantly, the correlation of technical replicates was very
high (Table 1), suggesting that variations introduced during
library construction and sequencing does not significantly
contribute to differences in gene expression between samples.
The correlation between replicate cultures grown in LB and
sequenced by Helicos and Illumina, respectively, was somewhat
lower (R = 0.73), suggesting some platform-specific biases. The
range of reads per ORF in the Illumina and Helicos datasets
varied between 0 and greater than 100,000 and 8,000, respec-
tively, reflecting a far more robust and sensitive dynamic
measurement of expression than previously obtained in microar-
ray-based approaches (Merrell et al., 2002; Xu et al., 2003; Bina
et al., 2003; Larocque et al., 2005).
Regardless of sequencing depth and technology, comparative
analyses revealed largely consistent global profiles for RNAs iso-
lated from all test conditions (Figures 1A, 1B, and S1 and Table
S1). Heat maps of ranked coverage revealed numerous regions
with transcript abundance that was uniformly high or uniformly
low in vivo and in vitro. (Figures 1A and 1B; inner 2 circles). Simi-
larly, for both sequencing technologies, plots of RPKMO (readser Inc.
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ORFs) were grossly similar for in vitro and in vivo-derived
RNAs (Figures 1A and 1B, third and fourth circles). For example,
chromosome I ori region transcripts were markedly more abun-
dant than those from chromosome termini (Figures 1A,1B, and
S1), consistent with expected differences in copy number due
to ongoing chromosome replication. Such differential expression
was absent for chromosome II, which as previously observed
yielded fewer transcripts overall than did chromosome I (Xu
et al., 2003). Additionally, for all samples, very few transcripts
corresponded to the 120 kb chrII superintegron (Heidelberg
et al., 2000), suggesting this gene capture system is not routinely
expressed in vitro or in vivo (Figures 1A, 1B, and S1).
The variance analysis package DEseq (Anders and Huber,
2010) was used to systematically search the transcriptome
data for the subset of genes with statistically significant (p <
1 3 105) and >4-fold differential expression in vivo compared
to in vitro (Figures 2A–2C and Table S2). Although expression
of most of V. cholerae’s genes did not markedly differ when cells
were obtained from an animal host rather than from in vitro
cultures (Figure 2A–2C), 478 were found to be induced in vivo
in at least one animal (Table S3), and 39 were induced in both
rabbits and mice compared to M9 and/or LB media (Figure 2E
and Table 2). The lack of complete overlap between the sets of
genes induced in the different animals likely reflects the different
sites from which bacteria were isolated (small intestine versus
cecal fluid) as well as host-specific differences.
Notably, the set of genes most highly induced in both animals
included all of the key known V. cholerae virulence factors and
most of the genes controlled by the virulence linked transcrip-
tional regulator ToxT (Krukonis and DiRita, 2003) (Figures 2A–
2C). Expression of ctxAB and genes enabling production of
TCP was induced 50- to more than 500-fold in rabbits and in
mice (Figures 1C, 2A–2C, and Table 2), and most of the remain-
ing genes in the TCP pathogenicity island were overexpressed at
least 20-fold in vivo (Figure 1C and Table 2). Such induction has
long been presumed to occur by cholera researchers, and was
confirmed for a few genes using low-throughput approaches
(Lee et al., 1999; Quinones et al., 2006). Quantitative RT-PCR
based analyses of ctxA and tcpA expression in rabbit ligated
loops yielded very similar magnitude of induction of these key
virulence genes (versus LB) as we found (Nielsen et al., 2010).
However, several earlier microarray-based studies failed to
obtain evidence supporting a dramatic induction of ToxT-regu-
lated genes (Merrell et al., 2002; Xu et al., 2003; Bina et al.,
2003) although one study noted such induction in upper intes-
tinal derived samples compared to stool samples (Larocque
et al., 2005) and another study detected induction in non-luminal
V. cholerae associated with the rabbit epithelium (Nielsen et al.,
2010). Significantly, virulence gene induction was detectable in
our RNA-seq studies even when infecting cells comprised only
a small proportion of the isolated tissue, a condition likely to
confound microarray-based analyses. Collectively, these data
indicate that RNA-seq enables sensitive, comprehensive, and
quantitative characterization of bacterial gene expression during
infection.
Given that many of the V. cholerae genes we observed to be
induced in both animal models (e.g., the TCP island genes) are
absolutely essential for colonization, we assessed whether otherCell Hossimilarly induced genes are likewise required. The colonization
capacities of 15 mutant strains, each lacking a single gene
whose expression was induced in vivo in both models, were
tested with in vivo competition assays in suckling mice. These
assays revealed that vc1773, which encodes a hypothetical
protein, promotes intestinal colonization (Table 2); interestingly,
it is encodedwithin theVibrio pathogenicity island 2 (VPI-2) along
with nanA (vc1776), which was previously shown to have a role
in vivo (Almagro-Moreno and Boyd., 2009). Mutants lacking
other genes that showed induction in vivo in both models were
not markedly attenuated in their ability to colonize the infant
mouse (Table 2).
Competition assays were also performedwith mutants lacking
a gene induced in just one of the two animal models, although
only a subset of these genes were tested. Of 26 strains with
insertion mutations that were tested, 8 displayed colonization
defects, which ranged from 3- to 10-fold (Table S5); 5 of these
were originally observed to be induced in rabbits and 3 in
mice. Thus, similar to the genes that were induced in both animal
models, only a subset of the genes induced in a single model
promotes growth in the mouse intestine. Collectively, these
observations indicate that other than the ToxT regulon, most
genes with elevated transcript abundance in either or both
rabbits and mice are apparently not critical for intestinal coloni-
zation. It is possible that expression of such genes facilitates
V. cholerae’s survival upon shedding or its transmission to a
new host (Schild et al., 2007); alternatively, induction may be a
reflection of the host environment yet not serve as a critical
adaptation to this environment. It should also be noted that
many genes previously shown to contribute to V. cholerae colo-
nization of the suckling mouse were not found to be induced
in vivo in our analyses (Ritchie and Waldor, 2009). Many of these
genes, including those encoding O-antigen biosynthesis, the
RNA chaperone Hfq, and TolC, yielded abundant transcripts
(coverage ranked in the top 20%) in vitro as well as in vivo (Table
S1), suggesting that their functions are not specifically adapted
for growth in the host.
To begin to understand the environment within the rabbit from
which V. cholerae was isolated, we performed mass spectro-
metric analyses of cecal fluid from infected rabbits and of
V. cholerae culture supernatants. The resulting data provided
plausible explanations for the expression of some V. cholerae
genes observed to be upregulated in the animal. For example,
we detected long chain fatty acids in cecal fluid but not in culture
supernatants (Figure S3). These molecules may account for the
elevated cecal expression of fadL (vc1042), a transporter of
long-chain fatty acids, and of the acyl CoA dehydrogenases
vc1740 and fadE (vc2231) in rabbits compared to either LB or
M9 (Figures 2A, 2C, and 3), as fatty-acid degradation (Fad)
gene expressionmay be induced to enable transport andmetab-
olism of host derived long chain fatty acids. Similarly, in vivo
induction of genes for glycerol transport (vca0137) and metabo-
lism, including glycerol kinase (vca0744) and glycerol 3-phos-
phate dehydrogenase (vca0747-0749), may facilitate utilization
of host-derived lipids.
Environmental conditions are also likely to account for the lack
of expression of iron uptake genes in bacteria isolated from
infected rabbits. Themajority of genes for both vibriobactin side-
rophore biosynthesis and transport (vc0474 (irgB), vc0475 (irgA),t & Microbe 10, 165–174, August 18, 2011 ª2011 Elsevier Inc. 167
Figure 1. V. cholerae Gene Expression in Culture and during Infection
(A and B) Profiles of V. cholerae gene expression in culture and during infection (A, rabbit [Illumina]; B, mouse [Helicos]). Plots for chromosome I are on the left and
for chromosome II are on the right and are based on data from two biological replicates for each condition. From inside to outside, the six circles in each plot
correspond to the following: (1 and 2) heatmap of ranked coverage in 5 kb windows in vitro and in vivo, respectively; (3 and 4) log2 of RPKMO (reads per kil-
obasepair of gene per million reads aligning to annotated ORFs) for each gene in vitro and in vivo, respectively. In circles 1–4, red, yellow, and blue correspond to
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vca0230) were found to be highly induced in the mouse small
intestine relative to LB but were uninduced in the rabbit relative
to LB (Figures 2A, 2B, and 3 and Table S4). Transcripts for
this set of genes were reduced in the rabbit and in LBmedia rela-
tive to in iron-poor M9 media (Figures 2C and 2D). Collectively,
these data suggest that iron is scarce in the mouse intestine
but readily available within the rabbit cecum. Heme, which is
detectable in the cecal fluid, may be a source of iron for the path-
ogen in the rabbit intestine (Figure S3).
Similarly, sulfate-containing compounds may be more avail-
able to bacteria within the rabbit than the mouse model. In the
rabbit, there is reduced expression of the majority of genes
(vc0538-0541, vc2558-2560, vc0384-0386) that are involved in
the acquisition and utilization of sulfate for generation of reduced
sulfur metabolites (such as thiols) (Figures 2A, 2C, and 3 and
Table S4), perhaps because there is cysteine in the cecal fluid
(Figure S3). In contrast, expression of these genes is equivalent
in the mouse intestine to what was detected in vitro (Figures 2B
and 3).
Transcription profiles derived from different growth conditions
can also provide clues for deciphering transcriptional architec-
ture and mechanisms that control transcription. For example,
analysis of transcripts from the TCP island clearly demonstrates
that tcpPH are not part of the operon that contains tcpA (Fig-
ure 1C). RNA-seq analysis also suggests that a predicted ribos-
witch upstream of a putative vitamin B12 receptor gene (vc0156)
enables downregulation of this gene in vivo. Coverage plots of
this region (Figure 4) are consistent with transcription attenuation
downstream of the putative riboswitch in vivo, but not in LB or
M9 media, suggesting that B12 (cobalamin) may be available
in the cecum (Nahvi et al., 2002). Searches for additional genes
with such uneven sequence coverage may facilitate identifica-
tion and characterization of riboswitches or other regulatory
processes.
RNA-seq proved highly sensitive for detection of known
ncRNAs, for discovery of new putative ncRNAs, and for identifi-
cation of ncRNAs differentially regulated in vivo (Tables S6, S7,
and S8). Of the 45 V. cholerae regulatory RNAs previously
characterized and/or predicted in the Rfam database, 42 were
detected with greater than 50 reads in at least one sample (Table
S1). These included the four rare Qrr sRNAs that govern
V. cholerae quorum sensing (Lenz et al., 2004), which were
detected in all samples, consistent with exponential phase
growth and with expression of virulence genes in vivo. The
iron-repressed sRNA RyhB was less abundant in the rabbit
cecum and in LB than in M9 medium and the mouse intestine,
providing further evidence that iron is not limiting in the cecum
but is in the mouse intestine. We also identified 77 putative inter-
genic sRNAs that had not been previously annotated (Table S6).windows/genes with high, middle, and low expression, respectively. (5) Regions
islands. (6) Log2 of fold abundance in vivo versus in vitro. Genes whose fold expres
in red and blue, respectively; the height of the bars corresponds to log2 of th
(Krzywinski et al., 2009).
(C) Strand-specific coverage per nucleotide across the genes within the TCP islan
a representative rabbit transcript library and red and green lines represent those fr
provide better definition of genomic regions with very high and low coverage. TC
Figure S1).
Cell HosSeven candidate or previously described sRNAs were overex-
pressed in rabbits (abundance increased 4-fold with p < .001)
compared to LB and M9 (Tables S7 and S8), including TarA,
which was independently discovered and shown to promote
intestinal colonization (Richard et al., 2010) and CsrC, another
sRNA that contributes to quorum sensing (Lenz et al., 2005).
Taken together, our results suggest that growth of V. cholerae
in vivo sets into action a complex transcriptional program that
includes two main sets of genes. The first set of genes encodes
many factors whose roles are central and/or specific to coloniza-
tion or virulence. Most of these genes are induced in diverse
hosts, often in response to the activator ToxT. However, a
subset, such as those of the VSP-1 (Dziejman et al., 2002) and
type VI secretion (T6S) genomic islands (Pukatzki et al., 2006)
are induced in the mouse intestine but not in the rabbit cecum,
and the signals that govern their expression remain to be identi-
fied. The second set of genes, which have not been linked to
virulence, likely encode factors primarily involved in metabolic
adaptations to environmental conditions that are host or niche
specific. Both metabolomic and detailed transcriptomic anal-
yses should facilitate further identification of the environmental
cues that govern expression of these genes.
The detailed characterization of gene expression during infec-
tion that can be obtained using RNA-seq should have wide-
spread utility in studies of pathogenesis. The approach allows
for simultaneous genome-wide identification of transcription
units, including rare transcripts and sRNAs, that are activated
in vivo, and also those that are repressed. Furthermore, it can
be used to analyze bacteria within infected tissues throughout
infection, rather than requiring isolation of bacteria that are
largely uncontaminated by host tissues. Consequently, the ap-
proach can simultaneously be used to monitor the physiology
of a host in response to a pathogen as well as the transcriptome
of commensal microbiota that coexist with the pathogen at the
site of infection (Rey et al., 2010). Transcript boundaries can
also be mapped with nucleotide resolution, thereby facilitating
identification of promoters, operons, and potential sites of tran-
scription attenuation. Finally, the output of RNA-seq analyses
can readily be standardized, which should facilitate comparisons
among studies and laboratories and promote a more compre-
hensive understanding of host-pathogen interactions.
EXPERIMENTAL PROCEDURES
Strains and Growth Conditions
A streptomycin-resistant derivative of the El Tor O1 V. cholerae clinical isolate
C6706 was used for this study. For in vitro RNA preparations, the strain was
grown to midexponential phase (O.D.600 0.4–0.6) in either LB or M9 media
supplemented with 0.2% glucose and 0.1% casamino acids at 37C. Where
required the media was supplemented with 200 mg/ml streptomycin and
40 mg/ml of X-Gal.encoding ribosomal proteins (black) or corresponding to indicated genomic
sion is statistically significant and >4-fold higher or lower in vivo are highlighted
e differential abundance in vivo versus LB. Plots were created using Circos
d. Blue and black lines represent read coverage sequenced and mapped from
om a representative Illumina LB library. Read depth is plotted on a log2 scale to
P genes are labeled and separated according to strand orientation. (see also
t & Microbe 10, 165–174, August 18, 2011 ª2011 Elsevier Inc. 169
Figure 2. Differential Gene Expression of Vibrio cholerae in Culture and during Infection
(A–D) MA plots of V. cholerae RNA-seq data. In these plots, each point represents an annotated ORF. The log2 of the ratio of abundances of each ORF between
the indicated conditions (M) is plotted against the average log2 of abundance of that ORF in all conditions (A). For each plot, M and A values were based on data
from two biological replicates from each growth condition or animal model. Genes that are significantly differentially expressed (based onDESeq analyses) as well
as several groups of genes that are mentioned in the text are highlighted with different symbols (see legend below plots).
(E) Venn diagram of genes overexpressed in mice and rabbits. Genes were considered overexpressed if their differential abundance between in vivo and in vitro
samples wasR4-fold and had a P value < 13 105. The 39 genes in the overlap between rabbits and mice include 10 of the 13 genes in the ToxT regulon (Bina
et al., 2003). (see also Figure S2 and Tables S2, S3, S4, and S5).
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Table 2. Relative In Vivo Fitness of V. cholerae Mutants Lacking Genes Induced in Both Rabbit and Mouse*
Locus No. # Gene Name Product
Fold Induction$
CI^ Reference
Rabbit
versus LB
Mouse
versus LB
vc0819 aldA Aldehyde dehydrogenase 78 2784 No defect (Parsot and Mekalanos, 1991)
vc0820 tagA ToxR-activated gene A 42 216 No defect (Parsot and Mekalanos, 1991)
vc0825 tcpI Toxin coregulated pilus
biosynthesis protein I
63 302 No defect (Parsot and Mekalanos, 1991)
vc0828-0839 tcpA,B,Q,C,
R,D,S,T,E,F,
toxT, tcpJ
Toxin coregulated pilus
biosynthesis proteins
55-7200 42-1000 <0.01 (Peterson & Mekalanos, 1988;
Kirn et al., 2003; Chiang and
Mekalanos, 1998)
vc0840-0845 acfB,C, orf4,
tagE, acfAD
Accessory colonization
factors, hypothetical protein,
and ToxR activated gene E
11-109 7-58 <0.08 except
Vc0842-0843
not known
(Peterson & Mekalanos, 1988)
vc1456-1457 ctxBA Cholera enterotoxin
subunits B and A
340-400 50-380 0.4 (ctxA) (Peterson & Mekalanos, 1988)
vc1773 Hypothetical protein 17 12 0.3
vc1774 Hypothetical protein 11 14 1.5
vc1776 nanA N-acetylneuraminate lyase 21 14 0.06 (Almagro-Moreno and Boyd, 2009)
vc2637 Peroxiredoxin family protein 12 9 1.2
vca0183 Nitric oxide dioxygenase 10 8 1.4
vca0241-0248 Ascorbate specific
PTS proteins
9-150 7-26 1.0 except
Vca0242 – 0.3
vca0556 Hypothetical protein 13 25 1.2
vca0749 glpC Sn-glycerol-3-phosphate
dehydrogenase subunit C
11 5 0.7
vca1063 speF Ornithine decarboxylase 8 8 1.6
*: This list corresponds to the 39 genes in the overlap region shown in Figure 2B.
#: Loci are taken from Vibrio cholerae O1 biovar El Tor str. N16961 Refseq NC_002505 and NC_002506.
$: This represents the mean values derived from two samples from either animal model or from LB. The ranges correspond to the values for the genes
listed.
^CI: competitive indices were calculated as the output ratio of mutant versus WT cells divided by the input ratio of mutant versus WT cells in an infant
mouse colonization assay. The values represent the means for at least five infant mice/group.
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Ten micrograms of in vivo-derived bacterial RNA was sequentially treated with
the MICROBEnrich and MICROBExpress kits (Ambion) to enrich for bacterial
RNA and mRNA, respectively. Ten micrograms of in vitro derived RNA was
subjected only to the MICROBExpress kit. Strand-specific libraries were
prepared using a dUTP second-strand marking protocol (Parkhomchuk
et al., 2009; Levin et al., 2010) with reagents from Invitrogen unless otherwise
stated. Bacterial mRNA was fragmented using a RNA fragmentation kit (Am-
bion), which yielded fragments in the range of 60–200 nts. First-strand cDNA
was synthesized from 400 ng of precipitated fragmented RNA, using 3 mg of
random primers, 4 mg actinomycin D, and Superscript III. Following extraction
and precipitation, second-strand cDNA was synthesized using dUTP (Applied
Biosystems) rather than dTTP as described (Levin et al., 2010). Paired-end
libraries for Illumina sequencing were prepared from purified cDNA (MinElute
PCR purification kit; QIAGEN) as recommended by Illumina, except that
the size-selected adaptor ligated cDNA was preincubated with 1 ml Uracil-N-
glycosylase (Applied Biosystems) at 37C for 15 min, followed by 95C for
5 min before the final PCR. PCR primers were removed using 1.8 volumes of
AMPure XP beads (Beckman Coulter).
Library Preparation for Helicos Sequencing
cDNA was prepared and modified for Helicos sequencing according to the
manufacturer’s protocol. A single-stranded cDNA library was prepared using
1 mg of purified RNA and 500 ng of random hexamers (Invitrogen) and RNA
was removed from the reaction using RNaseH and RNaseA. The cDNA library
was sheared at 4C using a Misonix 4000 with the amplitude set at 60% forCell Hos20 min (20 s on/off pulses), yielding primarily cDNA shorter than 200 nts
according to Bioanalyzer (Agilent Technologies). Sheared cDNA was treated
with terminal transferase (NEB) and dATP to generate the 100–200 nt
30 poly-A tail that is necessary for Helicos sequencing.
RNA-Seq Data Analysis
Reads were aligned to chromosomes I and II of V. cholerae N16961 (RefSeq
accession numbers NC_002505 and NC_002506) using MAQ 0.7.1-9
(Li et al., 2008) for Illumina reads and CLC_BIO (V4.5) for Helicos reads. The
subsequent bioinformatics analysis included the following stages: (1) The
number of reads aligning to each genomic position on each strand was calcu-
lated. (2) Each genomic position was annotated based on its location within
the sense or antisense strand of ORFs, rRNA, tRNA, or regRNA or in an inter-
genic region. Positions where the antisense strand of one gene overlapped the
sense strand of another were annotated as sense. Annotations of protein-
encoding genes were based on RefSeq NC_002505.gff and NC_002506.gff;
those of noncoding RNAs were derived from Rfam (v9.1) (Gardner et al.,
2009) or from published data. (3) The total number of reads aligning to each
category (e.g., ORFs, antisense to ORFs) and to each annotated gene was
calculated. (4) Total reads/gene were normalized using RPKM ([reads/kb
of gene]/[million reads aligning to genome]) or a variant we call RPKMO
([reads/kb of gene]/[million reads aligning to annotated ORFs]), enabling us
to account not only for differences in the total number of reads obtained in
each sample, but also for the often significant differences between samples
in the proportions of reads corresponding to rRNAs (Table S1). (5) Putative
transcription units (PTUs) were identified as stretches of 50–450 consecutivet & Microbe 10, 165–174, August 18, 2011 ª2011 Elsevier Inc. 171
Figure 3. Differential Expression of Functionally
Related Groups of Genes In Vivo Compared to in
Culture
Fold expression was calculated based on the average
M values calculated by DEseq for each group of genes.
The following genes were included in each group: TCP:
VC0825-0837; CTX: VC1456-1457; ACF: VC0840-0841,
VC0844-0845; iron: VC0200, VCA0227-0230, VCA0911-
0915, VC2209-2211, VC0771-VC0777; fatty acid: VC1042,
VC1740, VC2231, VCA0137, VCA0744, VCA0747-0749;
sulfate: VC2558, VC0538-0541, VC2559-2560, VC0384-
0386 (see also Figure S3).
Cell Host & Microbe
Monitoring Pathogen Gene Expression during Infection with RNA-Seqpositions with read coverage >20 that did not overlap annotated genes.
Overlapping PTUs from biological replicates were resolved to give the final
list of unique PTUs.Figure 4. Coverage Plots of RNA-Seq Reads Aligning to a Putative
Cobalamin-Regulated Riboswitch and Its Downstream Gene
y axis is linear and values are arbitrary units corresponding to reads/position.
The numbers in the corner of each plot correspond to the ratio of the
abundance of ORF reads (green) versus riboswitch region reads (red).
172 Cell Host & Microbe 10, 165–174, August 18, 2011 ª2011 Elsevier Inc.Identification of Differentially Expressed Genes
Differentially expressed genes were identified using
DEseq, a variance-analysis package that was developed
to infer statistically significant differences in gene-expres-
sion data from high-throughput sequencing (Anders and
Huber, 2010). Two biological replicates were included for
each growth condition or animal model, and comparisons
were conducted separately for Illumina and Helicos data-sets. For each sample, the number of reads per gene was normalized by
DEseq based on the total number of aligned reads for that sample. For calcu-
lation of A values, all geneswith less than one readwere assigned a value equal
to half the normalized value for the gene with the lowest abundance in that
sample and the mean of the log2 of normalized read/gene in each set of repli-
cates was calculated.M, the log2 of the ratio of A between each condition, was
then calculated based on these values.
Additional methods are presented in the Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, eight tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.chom.2011.07.007.
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